Pulmonary drug toxicity in patients with primary breast cancer treated with high dose combination chemotherapy and autologous bone marrow transplantation
Todd NW, Peters WP, Ost AH, Roggli VL (1993) Pulmonary drug toxicity in patients with primary breast cancer treated with high dose combination chemotherapy and autologous bone marrow transplantation. Am Rev Respir Dis 147:1264-1270
Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non Hodgkin lymphoma: Value of augmented preparative regimens. A southwest oncology group trial
Stiff PJ, Dahlberg S, Forman SJ, Mc Call AR, Horning SJ, Nademanee AP, Blume KG, Le Blanc M, Fisher RI (1998) Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non Hodgkin lymphoma: value of augmented preparative regimens. A southwest oncology group trial. J Clin Oncol 16:48-55
Pulmonary toxicity of high-dose chemotherapy for breast cancer: A non-invasive approach to diagnosis and treatment
Chap L, Shpiner R, Levine M, Norton L, Lill M, Glapsy J (1997) Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment. Bone Marrow Transplant 20:1063-1067
Amelioration of bleomycin-induced pulmonary injury by cyclosporine A
Lossos IS, Or R, Goldstein RH, Conner MW, Breuer R (1996) Amelioration of bleomycin-induced pulmonary injury by cyclosporine A. Exp Lung Res 22:337-349